Detalles de la búsqueda
1.
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
N Engl J Med
; 387(25): 2331-2343, 2022 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36546625
2.
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Clin Infect Dis
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739755
3.
Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial.
Lancet
; 400(10366): 1858-1868, 2022 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36368336
4.
The lived experiences of tuberculosis survivors during the COVID-19 pandemic and government lockdown in South Africa: a qualitative analysis.
BMC Public Health
; 23(1): 1729, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37670253
5.
A Randomized Clinical Trial of Human Papillomavirus Test-and-Treat as Compared to Cytology-Based Screening for Prevention of Cervical Cancer Among Women With Human Immunodeficiency Virus: AIDS Clinical Trials Group Protocol A5282.
Clin Infect Dis
; 75(8): 1280-1288, 2022 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35294524
6.
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.
Clin Infect Dis
; 60(10): 1541-9, 2015 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25681380
7.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Lancet Respir Med
; 12(2): 117-128, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980911
8.
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Lancet Infect Dis
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38768617
9.
The lived experiences of Tuberculosis survivors during the COVID-19 pandemic and government lockdown in South Africa: a qualitative analysis.
Res Sq
; 2023 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37205375
10.
Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial.
PLoS Med
; 9(6): e1001236, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22719231
11.
Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.
J Neurovirol
; 18(3): 162-71, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22528477
12.
Tuberculosis and Sexual and Reproductive Health of Women in Four African Countries.
Int J Environ Res Public Health
; 19(22)2022 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36429820
13.
Lung and blood early biomarkers for host-directed tuberculosis therapies: Secondary outcome measures from a randomized controlled trial.
PLoS One
; 17(2): e0252097, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35120127
14.
Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial.
Lancet
; 376(9734): 33-40, 2010 Jul 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-20557927
15.
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine.
AIDS
; 35(5): 759-767, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587439
16.
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.
Lancet Respir Med
; 9(8): 897-908, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33740465
17.
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy.
BMJ Open
; 10(10): e036599, 2020 10 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33039989
18.
Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.
Lancet Respir Med
; 7(12): 1048-1058, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31732485
19.
Raltegravir 1200 mg Once Daily vs 400 mg Twice Daily, With Emtricitabine and Tenofovir Disoproxil Fumarate, for Previously Untreated HIV-1 Infection: Week 96 Results From ONCEMRK, a Randomized, Double-Blind, Noninferiority Trial.
J Acquir Immune Defic Syndr
; 78(5): 589-598, 2018 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29771789
20.
Impact of early versus deferred antiretroviral therapy on estimated glomerular filtration rate in HIV-positive individuals in the START trial.
Int J Antimicrob Agents
; 50(3): 453-460, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28668686